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ABSTRACT 1 
Objectives: To study DNA methylation at the C19MC locus in the placenta and its association 2 
with: 1) parental body size, 2) transmission of haplotypes for the C19MC rs55765443 SNP, 3) 3 
offspring’s body size and/or body composition at birth and in childhood.  4 
Subjects and methods: Seventy-two pregnant women-infant pairs and 63 fathers were 5 
included in the study. Weight and height of mothers, fathers and newborns were registered 6 
during pregnancy or at birth (n=72). Placental DNA methylation at the C19MC imprinting 7 
control region (ICR) was quantified by bisulfite pyrosequencing. Genotyping of the SNP was 8 
performed using restriction fragment length polymorphisms. The children’s body size and 9 
composition were reassessed at age 6 years (n=32). 10 
Results: Lower levels of placental C19MC methylation were associated with increased body 11 
size of the mother, specifically with higher pre-gestational and pre-delivery weights and 12 
height (β from –0.294 to –0.371; R2 from 0.04 to 0.10 and all p<0.019), and with higher 13 
weight, height, waist and hip circumferences, and fat mass of the child (β from –0.428 to –14 
0.552; R2 from 0.33 to 0.56 and all p<0.009). Parental transmission of the SNP did not 15 
correlate with an altered placental methylation status at the C19MC ICR.  16 
Conclusions: Increased maternal size is associated with reduced placental C19MC 17 
methylation, which, in turn, relate to larger body size of the child. 18 
 19 
Keywords: maternal size, DNA methylation, programming, rs55765443. 20 
 21 
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INTRODUCTION 1 
Genomic imprinting is a complex epigenetically-regulated phenomenon by which some 2 
genes become mono-allelically expressed in a parent-of-origin specific manner.1, 2 Imprinted 3 
genes play essential roles in prenatal growth of the embryo and/or placenta functions.3-6  4 
In the human placenta, the chromosome 19 microRNA cluster (C19MC) is imprinted, 5 
and is expressed exclusively from the paternally inherited allele as confirmed by the 6 
genotyping of a single nucleotide polymorphism (SNP: G or T, rs55765443) mapping upstream 7 
the most-5’ microRNA transcribed by C19MC.7 This primate-specific microRNA cluster spans 8 
∼100 kb and produces 56 mature microRNAs.8, 9 The cluster is governed by the DNA 9 
methylation status of an imprinting control region (ICR) located about 17.6 kb upstream the 10 
microRNA cluster.7, 10 C19MC, which is expressed almost exclusively in placenta,11 is believed 11 
to play important roles in the regulation of cellular differentiation, trophoblast migration and 12 
immunomodulation during pregnancy.12, 13 Altered expression of C19MC has been reported in 13 
gestational hypertension, preeclampsia and fetal growth restriction.12, 13  14 
Fetal growth and postnatal development, which are critical processes of life, are 15 
regulated by genetic and epigenetic factors. SNPs located within or in the vicinity of imprinted 16 
genes correlate with fetal growth characteristics in a parent-of-origin manner.14, 15 Non-17 
genetic variation or pathological disruption of DNA methylation marks in several imprinted 18 
loci, including  IGF2-H19, GNAS or DLK1-DIO3, have been consistently related to changes in 19 
pre- and postnatal growth as well.16-19 20 
Currently, there are no reports of parental factors related to placental C19MC 21 
methylation variation, nor about the impact of C19MC differential methylation on the 22 
offspring’s development. Here, we examined for the first time the placental C19MC DNA 23 
methylation levels and their association with 1) parental weight and height, 2) parental 24 
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transmission of haplotypes within a SNP (rs55765443) in C19MC, 3) postnatal growth and 1 
body composition of the offspring at birth and in childhood, and 4) gene expression levels of 2 
representative C19MC miRNAs. 3 
 4 
5 
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METHODS 1 
 2 
Study population and ethics 3 
The study population included 72 pregnant Caucasian women who delivered healthy 4 
infants, and 63 of the respective fathers who also accepted to participate in this longitudinal 5 
cohort study (Table 1). The subjects were recruited during the first trimester of pregnancy 6 
among those seen within a setting of prenatal primary care in l’Alt Empordà and Girona 7 
(North-eastern Spain) from 2008 to 2010. Information on pregnancy, labor and delivery 8 
characteristics was retrieved from standardized medical records. Pregnancies resulting from 9 
assisted reproductive technology (ART) were excluded because ART may perturb imprinting.20 10 
Women with major medical, surgical or obstetrical complications, including multiple 11 
pregnancies, hypertension, gestational diabetes or preeclampsia, and fetal growth restriction, 12 
malformations or asphyxia were also excluded.  13 
The protocol was approved by the Institutional Review Board of Dr. Josep Trueta 14 
Hospital (Reference number: 2013132; Approval date: November 24th 2014) and informed 15 
written consent was obtained from all parents.  16 
 17 
Anthropometric assessments 18 
Father’s weight and height were measured at inclusion without shoes and wearing 19 
light clothes; maternal weight and height were assessed similarly at each trimester of 20 
gestation. Body-mass index (BMI) was calculated as weight divided by height squared (Kg/m2).  21 
All infants were born at term of pregnancy. After delivery, weight and length were 22 
measured using a calibrated scale and a measuring board. Gestational age- and sex-adjusted 23 
z-scores for birth weight and length were calculated using regional norms.21 From the children 24 
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included at birth, those whose parents agreed that they could participate further in the study 1 
(n=32) were followed-up at the age of 6 years. Their characteristics at birth did not differ from 2 
those who did not participate in the follow-up study. Weight was measured on a calibrated 3 
scale wearing light clothes, and height was measured with a Harpenden stadiometer without 4 
shoes. BMI and age- and sex-adjusted z-scores were calculated as above. Waist circumference 5 
was measured in the supine position at the umbilical level. Hip circumference was measured 6 
at the widest part, at the level of the greater trochanters. 7 
Fat measurements  8 
Fat mass was assessed by bioelectric impedance (Hydra Bioimpedance Analyzer 4200; 9 
Xitron Technologies, San Diego CA), at the age of 6 years, as previously described in 10 
prepubertal children.22  11 
Visceral fat was estimated as described by Hirooka et al23 using high-resolution 12 
ultrasonography (MyLabTM25, Esaote, Italy) in a transverse abdominal scan with a convex 3-13 
3.5 MHz transducer, with minimal pressure applied to prevent compression of the fat layers. 14 
Measurement of visceral fat by ultrasound correlates well with that measured by computed 15 
tomography.23, 24 All images were obtained with the subject in supine position at the end of a 16 
normal exhalation and performed by the same observer. The average of three measurements 17 
was used for all sites; the intra-subject coefficient of variation was <6%.  18 
 19 
Sample collection 20 
Blood samples were drawn from both progenitors in EDTA tubes at the initial visit. 21 
Samples were centrifuged at 2000 x g for 15 minutes at 4ºC and total leukocytes were 22 
harvested. The placentas were collected immediately after childbirth. Three cuboidal biopsies 23 
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(1 cm3) containing placental villous tissue, were dissected from the non-membranous surface 1 
(maternal side) of placentas after removing the decidua (outermost layer) midway between 2 
the umbilical cord and the placental margin. The same location was used when sampling all 3 
placentas to reduce interplacental variability. All samples were stored at -80ºC.  4 
 5 
DNA methylation analysis  6 
Quantitative DNA methylation analysis was performed by pyrosequencing of 7 
bisulphite-treated DNA.25 Genomic DNA was extracted from placentas using the Gentra 8 
PureGene tissue kit (Qiagen, Germany). Sodium bisulfite conversion of 500 ng of DNA was 9 
performed using the EZ DNA Methylation-Gold kit (Zymo Research, Irvine CA). Bisulphite-10 
treated DNA (20 ng) was amplified with 0.3 µM of forward and biotinylated reverse primers 11 
(Supplementary Table S1). Reactions were performed in 1X Taq GOLD buffer adjusted to 12 
1.5 mM MgCl2, 0.2 mM dNTPs and 1 U of Taq GOLD polymerase (Qiagen) in a total volume of 13 
35 µl. PCR cycling steps were: 15 min at 94°C followed by 40 cycles of 20 s at 94°C, 30 s at 14 
58.6ºC and 1 min at 72°C, with a final extension of 10 min at 72°C. PCR product was rendered 15 
single-stranded25 and 4 pmol of the sequencing primer (Supplementary Table S1) were added 16 
following pyrosequencing in PyroMark Q96 ID and Q96 MD instruments (Qiagen). Raw data 17 
were analyzed using the Q-CpG software (V.1.0.9, Biotage AB), which calculates the ratio of 18 
converted Cs (Ts) to unconverted Cs at each CpG, giving the percentage of methylation. All 19 
reactions were run in duplicates. We analyzed 5 consecutive CpG dinucleotides located within 20 
the C19MC ICR (chr19:53648001-53648160 from UCSC Genome Browser, Human Dec. 2013 21 
(GRCh38/hg38) Assembly, Supplementary Figure S1A). The overall DNA methylation level 22 
across the C19MC ICR was defined as the average of methylation at all 5 CpG sites.  23 
8 
 
Genotyping (Restriction Fragment Length Polymorphisms, RFLPs) 1 
Mother-father-child trios were genotyped in order to study the paternal and maternal 2 
transmission of rs55765443 SNP alleles to the child. To assess parental genotype, DNA was 3 
extracted from parental blood leukocytes using the Gentra PureGene blood kit (Qiagen). For 4 
fetal genotyping, DNA was extracted from placentas as described above. DNA (10 ng) was 5 
amplified in a 10 µl reaction with 1x NH4 buffer supplemented with 1.5 mM MgCl2, 0.2 mM 6 
dNTPs, 0.5 U BIOTAQ DNA Polymerase (Bioline, Memphis TN) and 0.6 pmol/µl of each primer. 7 
PCR primers (chr19:53665044; UCSC Genome Browser, Human Dec. 2013 (GRCh38/hg38) 8 
Assembly) were: forward 5’-TGTGGCCAGACTTTAATCCA-3’ and reverse 5’-9 
TTGGAGATTTTAGGGGGAGTC-3’. PCR conditions were: 94ºC for 5 min; 20 cycles of 94ºC 45 s, 10 
64ºC 45 s (decreasing 0.5ºC each cycle) and 72ºC 45s; 15 cycles of 94ºC 45 s, 54ºC 45 s and 11 
72ºC 45s; and 72ºC for 10 min. PCR product (207 bp) was then digested with 1 U of BsoBI 12 
restriction enzyme (New England Biolabs, Ipswich Massachusetts) at 37ºC for 16 hours. The 13 
fragments were visualized by electrophoresis through a 2% (w/v) agarose gel. The different 14 
genotypes were assessed according to the size and pattern of distribution of the fragments 15 
(Homozygous T: 1 band 207 bp; Heterozygous: 3 bands of 207, 152 and 55 bp; Homozygous G: 16 
2 bands of 152 and 55 bp). Mother-father-child trios that were all heterozygous were 17 
uninformative for imputing parental allelic transmission, thus the final number of samples 18 
used in the analysis was 53 trios. All SNP genotypes were shown to be consistent with Hardy–19 
Weinberg equilibrium (χ2 test p=0.900). 20 
 21 
Gene expression analysis by Real Time-PCR 22 
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Total RNA was extracted and retrotranscribed using the RNeasy mini kit (Qiagen) and the 1 
Megaplex Human RT Primers (Pool A v2.1) with MultiScribe Reverse Transcriptase 2 
(Thermofisher Scientific, Waltham, MA). The following TaqMan Gene Expression assays 3 
(Thermofisher Scientific) were used to amplify the cDNA: miR-517a (Ref#002402), miR-517c 4 
(Ref#001153), miR-520c (Ref#002389), miR-520g (Ref#001121) and the endogenous controls 5 
miR-523 (Ref#002386), miR-532 (Ref#001518) and miR-425-5p0 (Ref#425-5p).26 Reactions 6 
were run on a LightCycler 480 Real-Time PCR System (Roche Diagnostics, Rotkreuz, 7 
Switzerland), using the default cycling conditions. Relative mRNA levels were calculated 8 
according to the 2–ΔCT method. 9 
Statistics 10 
Statistical analyses were performed using the SPSS 22.0 package (SPSS Inc). Non-11 
normally distributed data was log-transformed to improve symmetry. The relationship 12 
between DNA methylation levels and both anthropometric parameters and gene expression 13 
was tested by Pearson correlation followed by multiple regression analysis using the enter 14 
method to adjust for possible confounding variables (maternal pre-gestational and gestational 15 
weight, maternal height, gestational age, birth weight or length, and child’s sex, age and BMI). 16 
Differences in DNA methylation levels among haplotypes were examined by unpaired 17 
Student’s T-test. Accepting an alpha risk of 0.05 in a bilateral contrast, the study has an 80% 18 
power to detect a significant Pearson correlation coefficient of at least 0.5 between variables, 19 
and a difference of at least 5 units in DNA methylation between groups assuming a standard 20 
deviation (SD) of 5 units (GRANMO, IMIM, version 7.12). When analyzing the percentage of 21 
methylation of each CpG, the statistical significance was set at 0.0125 after applying the 22 
10 
 
Bonferroni correction for subgroup analyses (0.05/4 subgroup analyses: maternal 1 
characteristics, paternal characteristics, data at birth and childhood data). 2 
3 
11 
 
RESULTS  1 
Subjects 2 
Table 1 shows the clinical variables in the parents and their children, at birth and at 6 3 
years of age. Maternal anthropometric variables (height, pre-gestational and predelivery 4 
weights, and pregestational BMI) associated with offspring’s variables (weight, height and 5 
BMI) at birth and 6 years of age (Supplementary Table S2).  6 
 7 
DNA Methylation levels at C19MC in placental tissue 8 
DNA methylation levels of the 5 studied CpGs within the ICR region of C19MC 9 
(Supplementary Figure S1A) were assessed by pyrosequencing. The percentage of DNA 10 
methylation in placenta for each CpG and the average methylation for all CpGs are shown in 11 
Supplementary Figure S1B. Average methylation levels of the combined CpGs at C19MC ICR 12 
ranged from 26 to 56% with mean and SD values of 42.7 ± 7.9 %. The methylation levels at the 13 
different CpGs analyzed were highly concordant. This indicates that methylation was affected 14 
similarly across the entire genomic region. 15 
 16 
Higher maternal size correlates with lower C19MC methylation in the placenta 17 
Firstly, we aimed to study the relationship between methylation levels at the C19MC 18 
ICR and parental phenotype. Higher maternal pre-gestational weight (r=–0.316, p=0.007), 19 
height (r=–0.291, p=0.013) and BMI (r=–0.237, p=0.045), as well as pre-delivery weight (r=–20 
0.376, p=0.002), associated with lower mean methylation levels at the placental C19MC ICR 21 
(Figure 1 A-C and Supplementary Table S3). Paternal anthropometric variables were not 22 
related to methylation levels within the placental C19MC cluster (Supplementary Table S3).  23 
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Following correction for multiple testing, maternal pre-gestational weight, height and pre-1 
delivery weight remained significantly associated with mean methylation at C19MC ICR (all 2 
p≤0.01). Maternal pre-gestational weight (p=0.011), height (p=0.019) and pre-delivery weight 3 
(p=0.003) independently explained mean placental C19MC methylation levels in multivariate 4 
linear models after adjusting for the following confounding variables: maternal age, 5 
gestational age and child’s sex, with model R2 of 0.05, 0.04 and 0.10, respectively 6 
(Supplementary Table S4).  7 
 8 
Parentally transmitted alleles for the rs55765443 SNP and placental C19MC DNA methylation  9 
We further assessed whether placental C19MC ICR methylation levels were related to 10 
the parental transmission of the rs55765443 SNP within the C19MC cluster. Maternally 11 
transmitted haplotypes had no significant effect on placental C19MC methylation levels 12 
(Supplementary Figure S2A and Table S5).  13 
Fetal inheritance of the paternal T allele was associated with lower methylation levels 14 
(39.8 ± 2.0 %) when compared with the G allele (47.2 ± 2.0 %) only at CpG5 of C19MC ICR 15 
(p=0.05, Supplementary Table S5). As for mean C19MC ICR methylation levels, the difference 16 
between T (41.0 ± 1.4 %) and G alleles (45.3 ± 1.6 %, Supplementary Figure 2B and Table S5) 17 
approached significance (p=0.059). However, none of these associations remained significant 18 
after correction for multiple testing. 19 
 20 
Lower placental C19MC methylation levels associates with bigger offspring’s size at 6 years of 21 
age 22 
Next, we examined the consequences of the differential DNA methylation at the 23 
placental C19MC ICR on the offspring at birth and at age 6 years. At birth, no statistically 24 
13 
 
significant relationships between newborns’ anthropometric variables and C19MC 1 
methylation levels were observed (Supplementary Table S6). However, lower mean 2 
methylation levels at placental C19MC ICR correlated with larger children’s size and fat 3 
abundance at age 6 years [weight (p≤0.001), height (p=0.001), BMI (p=0.017), waist (p=0.003), 4 
hip (p=0.003), fat mass (p=0.005) and visceral fat (p=0.009); Figure 2 and Supplementary Table 5 
S6].  6 
The correlations between methylation at C19MC ICR and weight, height, waist 7 
circumference, hip circumference, fat mass or visceral fat in the offspring remained significant 8 
after correction for multiple testing (all p≤0.0125). Placental C19MC ICR methylation levels 9 
also remained independently associated with children’s anthropometric variables (weight, 10 
height, waist and hip) after adjusting for confounding variables, including maternal weight or 11 
height, in general linear models (Table 2). The association of C19MC ICR methylation with fat 12 
mass, but not that with visceral fat, was also independent of confounding variables (Table 2).  13 
 14 
Placental C19MC ICR methylation levels and gene expression 15 
Finally, we investigated the potential link between C19MC ICR methylation and gene 16 
expression in the placental samples. Due to the complexity of this locus, which is transcribed 17 
as a single pri-miRNA and post-transcriptionally processed to generate numerous miRNAs 18 
with a wide range of expression levels,27, 28 we quantified the expression of representative 19 
miRNAs (miR-517a, miR-517c, miR-520c and miR-520g) in 56 placental samples. These miRNAs 20 
were chosen in order to have diverse expression levels (high, medium, low) and a wide 21 
coverage across the cluster. Median expression of the 4 analyzed miRNAs was used in order to 22 
approximate the gene expression levels of C19MC. In a bivariate correlation analysis, 23 
increased C19MC ICR methylation associated with reduced median miRNA expression (r= 24 
14 
 
‒0.267, p=0.047; Figure 3). This finding suggests that ICR methylation negatively affects 1 
miRNA expression across the locus.  2 
3 
15 
 
DISCUSSION 1 
Although altered expression of imprinted gene clusters has been linked to postnatal 2 
growth disorders,29 evidence that the placental imprinted C19MC cluster may play a role in 3 
this process is missing. Here, we show for the first time that, in the placenta, the level of 4 
methylation at the C19MC ICR is linked to maternal weight and height, and is ultimately 5 
related to the offspring’s body size and body composition in childhood.  6 
Interestingly, placental C19MC ICR methylation associated with the offspring’s 7 
anthropometry, independently of maternal weight and height. The association found in our 8 
cohort, between maternal weight/height and offspring’s weight/height, may be explained at 9 
least partially by placental C19MC ICR methylation levels. Thus, besides genetic factors,30 the 10 
offspring’s size may be significantly modulated by epigenetic factors at early stages of life. 11 
More generally, and in agreement with our finding, gene variants associated with height or 12 
BMI have been found to account for only around 20% of the heritable phenotypic variation.31, 13 
32  14 
Different studies have shown that maternal size correlates with the offspring’s growth 15 
and body composition.33-35 Our results suggest a possible role for placental C19MC ICR 16 
methylation in the modulation of childhood growth. Similarly, placental DNA methylation at 17 
the IGF2-H19, GNAS and DLK1-DIO3 imprinted loci has been linked to pre and postnatal 18 
growth characteristics.16, 18, 19 Moreover, our results link placental C19MC ICR methylation to 19 
the body composition of the offspring in childhood. Interestingly, maternal obesity has been 20 
suggested to alter adipocyte commitment and differentiation in the offspring via an 21 
epigenetic mechanism as well.36 Our findings suggest that maternal size and offspring fat mass 22 
at 6 years of age may, at least in part, be linked to C19MC methylation.  23 
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It has been shown that maternal factors, such as nutrient supplementation or alcohol 1 
intake, can alter DNA methylation patterns of imprinted genes with paternal expression, for 2 
instance at MEST, PLAGL1 or IGF2.37-40 It is therefore plausible that maternal body weight or 3 
height, may also influence placental methylation as well. In principle, the maternal allele is 4 
virtually 100% methylated at C19MC, as opposed to the paternal allele, which is 0% 5 
methylated. However, we found C19MC ICR global methylation to be less than 50% in most 6 
cases. This suggested that the maternal allele had partially lost its imprinting marks, thus 7 
allowing limited maternal expression and probably leading to functional consequences due to 8 
the high dosage sensitivity of imprinted gene expression.41  9 
In contrast to pre-gestational maternal weight, gestational weight gain cannot be 10 
directly linked to placental C19MC ICR methylation. Indeed, previous studies have suggested 11 
that nutrition throughout gestation does not contribute to the epigenetic reprogramming of 12 
the ICRs of GNAS, GRB10, KCNQ1OT1/CDKN1C and H19/IGF2 loci.42, 43 These findings could be 13 
related to the imprinted condition of the studied gene clusters. DNA methylation at ICRs of 14 
imprinted genes is acquired during gametogenesis, thus establishing germline-derived 15 
differentially methylated regions, and is refractory to the genome-wide methylation 16 
reprogramming that occurs in the embryo after fertilization.20, 29, 44 Accordingly, maternal 17 
weight during oogenesis and early embryogenesis, rather than gestational weight gain, could 18 
affect the DNA methylation at the imprinted C19MC ICR.  19 
DNA methylation levels can also be modified by the presence of specific SNPs.45 SNPs 20 
neighboring CpG islands, such as rs55765443, can lead to allele-specific DNA methylation 21 
changes, usually in a cis-acting mechanism.46 In this line, several obesity-associated SNPs have 22 
been reported to be associated with methylation levels at proximal CpG sites.47 In the C19MC 23 
cluster, the maternal allele is methylated by a specific imprint acquired in oocytes,7 thus it 24 
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would be plausible that a SNP in the maternally transmitted allele could affect C19MC ICR 1 
methylation levels. We therefore studied the relationship of the maternal and paternal alleles 2 
for the rs55765443 SNP with methylation levels. While no association was evident for 3 
transmission of the maternal allele and C19MC ICR methylation levels, we found a tendency 4 
for the paternally transmitted allele to be associated with altered methylation levels, which 5 
was not confirmed in adjusted analyses. We cannot rule out the possibility that other SNPs 6 
located close to this region could be linked to altered methylation levels of the C19MC ICR.  7 
Epigenetic variations at placental C19MC may be associated with concordant levels of 8 
change in gene expression that could explain the observed link between the cluster and 9 
offspring’s anthropometry. In fact, C19MC microRNAs can traffic among placental, maternal 10 
and fetal compartments,48 feasibly influencing fetal programming and thus the developmental 11 
trajectory. Computational and bioinformatic analyses have predicted that C19MC miRNAs 12 
participate in reproduction, development, and differentiation,49 including stem cell self-13 
renewal and pluripotency by controlling G1-S transition and apoptosis signaling.50 Indeed, 14 
members of the C19MC cluster have been shown to regulate cellular reprogramming, 15 
enhance proliferation and suppress apoptosis.51 Regarding our results, a possible hypothesis is 16 
that differential methylation at the C19MC cluster may cause molecular changes in fetal 17 
tissues, probably in stem cells, through variations in microRNAs levels. C19MC microRNAs may 18 
thus target and prime specific fetal tissues, such as adipose tissue, for enhanced proliferation 19 
later in life. This hypothesis could not be tested in our study. Instead, we analyzed the 20 
expression levels of representative C19MC miRNAs in placental tissue and found that 21 
methylation levels in this locus associated with miRNA expression levels. Although the 22 
molecular changes may be rather fast, the anthropometric changes (weight, height or fat 23 
18 
 
mass) could need more time to be revealed, and thus they may not be seen until childhood, 1 
explaining the lack of association with infants’ anthropometry.   2 
We acknowledge some study limitations. The specific role for the rs55765443 paternal 3 
haplotype on C19MC methylation, as well as the interaction between the paternally 4 
transmitted allele and maternal size as modifiers of the placental C19MC ICR methylation 5 
levels, need to be addressed in additional studies. A next step should also include the analysis 6 
in fetal tissues of gene expression levels of the 56 microRNAs encoded by C19MC cluster, 7 
which was beyond the scope of the current study. Finally, other factors such as diet or other 8 
environmental factors were not included in the current analysis but should be considered for 9 
further studies as possible confounders.  10 
The strengths of our study include the follow-up data on the offspring. Moreover, due 11 
to the crucial role of imprinted genes in early life development, the significance of our study is 12 
warranted, since elucidating the factors that affect their epigenetic regulation has important 13 
implications for understanding the causes of human health and disease, and may help to 14 
establish protocols for early detection/prevention of adult diseases. Finally, the use of 15 
placenta to predict complications later in life would have obvious advantages, as it is an easily 16 
available tissue that can be sampled non-invasively. 17 
 In summary, maternal size associates with the percentage of methylation within the 18 
placental C19MC ICR, and such methylation levels are related to offspring’s size and body 19 
composition at age 6 years. Increased maternal size may reduce placental C19MC 20 
methylation, in turn leading to larger size of the offspring in childhood. These results may help 21 
to establish protocols for early detection/prevention of childhood/adulthood diseases related 22 
to body size and composition. 23 
 24 
19 
 
Acknowledgments: The authors are grateful to all the children and parents who participated 1 
in the study. AP-P was granted with CAS14/00011 (Spanish Ministry of Education, Culture and 2 
Sport). SX-T holds a Sara Borrell contract from Carlos III National Institute of Health (ISCIII; 3 
CD15-00162). GC-B was granted a pFIS contract from ISCIII. BM-P holds a contract from 4 
Generalitat de Catalunya (SLT002/16/00065). JB is a Miguel Servet investigator from ISCIII 5 
(MS12/03239). FdZ is a Senior Investigator of the Clinical Research Fund of the Leuven 6 
University Hospital. LI is a Clinical Investigator of CIBERDEM (Spanish Biomedical Research 7 
Centre in Diabetes and Associated Metabolic Disorders), from ISCIII. AL-B is an I3 investigator 8 
(Spanish Ministry of Economy and Competitiveness).  9 
This study was supported by grants from the Ministerio de Ciencia e Innovación, Instituto de 10 
Salud Carlos III (ISCIII), Madrid, Spain (PI17/00557 to JB, and PI13/01257 and PI16/01335 to 11 
AL-B), projects co-funded by FEDER (Fondo Europeo de Desarrollo Regional). RF and MG 12 
acknowledge grant funding from the Fondation pour la Recherche Médicale (Equipes FRM, 13 
grant number DEQ31703). 14 
 15 
The authors declare that they have no conflicts of interest.  16 
 17 
Supplementary information is available at International Journal of Obesity’s website.  18 
19 
20 
 
REFERENCES 1 
1. Koerner MV, and Barlow DP. Genomic imprinting-an epigenetic gene-regulatory 2 
model. Curr Opin Genet Dev 2010; 20:164-170. 3 
2. Reik W, and Walter J. Genomic imprinting: parental influence on the genome. Nat Rev 4 
Genet 2001; 2:21-32. 5 
3. Davies W, Isles AR, Humby T, and Wilkinson LS. What are imprinted genes doing in the 6 
brain? Adv Exp Med Biol 2008; 626:62-70. 7 
4. Tycko B. Imprinted genes in placental growth and obstetric disorders. Cytogenet 8 
Genome Res 2006; 113:271-278. 9 
5. Smith FM, Garfield AS, and Ward A. Regulation of growth and metabolism by 10 
imprinted genes. Cytogenet Genome Res 2006; 113:279-291. 11 
6. Girardot M, Feil R, and Lleres D. Epigenetic deregulation of genomic imprinting in 12 
humans: causal mechanisms and clinical implications. Epigenomics 2013; 5:715-728. 13 
7. Noguer-Dance M, Abu-Amero S, Al-Khtib M, Lefevre A, Coullin P, Moore GE, et al. The 14 
primate-specific microRNA gene cluster (C19MC) is imprinted in the placenta. Hum 15 
Mol Genet 2010; 19:3566-3582. 16 
8. Bentwich I, Avniel A, Karov Y, Aharonov R, Gilad S, Barad O, et al. Identification of 17 
hundreds of conserved and nonconserved human microRNAs. Nat Genet 2005; 37:766-18 
770. 19 
9. Bortolin-Cavaille ML, Dance M, Weber M, and Cavaille J. C19MC microRNAs are 20 
processed from introns of large Pol-II, non-protein-coding transcripts. Nucleic Acids Res 21 
2009; 37:3464-3473. 22 
21 
 
10. Tsai KW, Kao HW, Chen HC, Chen SJ, and Lin WC. Epigenetic control of the expression 1 
of a primate-specific microRNA cluster in human cancer cells. Epigenetics 2009; 4:587-2 
592. 3 
11. Mouillet JF, Ouyang Y, Coyne CB, and Sadovsky Y. MicroRNAs in placental health and 4 
disease. Am J Obstet Gynecol 2015; 213:S163-172. 5 
12. Hromadnikova I, Kotlabova K, Ondrackova M, Pirkova P, Kestlerova A, Novotna V, et al. 6 
Expression profile of C19MC microRNAs in placental tissue in pregnancy-related 7 
complications. DNA Cell Biol 2015; 34:437-457. 8 
13. Xie L, Mouillet JF, Chu T, Parks WT, Sadovsky E, Knofler M, et al. C19MC microRNAs 9 
regulate the migration of human trophoblasts. Endocrinology 2014; 155:4975-4985. 10 
14. Ishida M, and Moore GE. The role of imprinted genes in humans. Mol Aspects Med 11 
2013; 34:826-840. 12 
15. Richard N, Molin A, Coudray N, Rault-Guillaume P, Juppner H, and Kottler ML. Paternal 13 
GNAS mutations lead to severe intrauterine growth retardation (IUGR) and provide 14 
evidence for a role of XLalphas in fetal development. J Clin Endocrinol Metab 2013; 15 
98:E1549-1556. 16 
16. Bourque DK, Avila L, Penaherrera M, von Dadelszen P, and Robinson WP. Decreased 17 
placental methylation at the H19/IGF2 imprinting control region is associated with 18 
normotensive intrauterine growth restriction but not preeclampsia. Placenta 2010; 19 
31:197-202. 20 
17. Brehin AC, Colson C, Maupetit-Mehouas S, Grybek V, Richard N, Linglart A, et al. Loss 21 
of methylation at GNAS exon A/B is associated with increased intrauterine growth. J 22 
Clin Endocrinol Metab 2015; 100:E623-631. 23 
22 
 
18. St-Pierre J, Hivert MF, Perron P, Poirier P, Guay SP, Brisson D, et al. IGF2 DNA 1 
methylation is a modulator of newborn's fetal growth and development. Epigenetics 2 
2012; 7:1125-1132. 3 
19. Prats-Puig A, Carreras-Badosa G, Bassols J, Cavelier P, Magret A, Sabench C, et al. The 4 
placental imprinted DLK1-DIO3 domain: a new link to prenatal and postnatal growth in 5 
humans. Am J Obstet Gynecol 2017; 217:350 e351-350 e313. 6 
20. Grafodatskaya D, Cytrynbaum C, and Weksberg R. The health risks of ART. EMBO Rep 7 
2013; 14:129-135. 8 
21. Carrascosa A, Fernandez JM, Fernandez C, Ferrandez A, Lopez-Siguero JP, Sanchez E, et 9 
al. Spanish growth studies 2008. New anthropometric standards. Endocrinol Nutr 10 
2008; 55:484-506. 11 
22. Treuth MS, Butte NF, Wong WW, and Ellis KJ. Body composition in prepubertal girls: 12 
comparison of six methods. Int J Obes Relat Metab Disord 2001; 25:1352-1359. 13 
23. Hirooka M, Kumagi T, Kurose K, Nakanishi S, Michitaka K, Matsuura B, et al. A 14 
technique for the measurement of visceral fat by ultrasonography: comparison of 15 
measurements by ultrasonography and computed tomography. Intern Med 2005; 16 
44:794-799. 17 
24. Ferrozzi F, Zuccoli G, Tognini G, Castriota-Scanderbeg A, Bacchini E, Bernasconi S, et al. 18 
[An assessment of abdominal fatty tissue distribution in obese children. A comparison 19 
between echography and computed tomography]. Radiol Med 1999; 98:490-494. 20 
25. Tost J, and Gut IG. DNA methylation analysis by pyrosequencing. Nat Protoc 2007; 21 
2:2265-2275. 22 
23 
 
26. Carreras-Badosa G, Bonmati A, Ortega FJ, Mercader JM, Guindo-Martinez M, Torrents 1 
D, et al. Dysregulation of Placental miRNA in Maternal Obesity Is Associated With Pre- 2 
and Postnatal Growth. J Clin Endocrinol Metab 2017; 102:2584-2594. 3 
27. Bellemer C, Bortolin-Cavaille ML, Schmidt U, Jensen SM, Kjems J, Bertrand E, et al. 4 
Microprocessor dynamics and interactions at endogenous imprinted C19MC microRNA 5 
genes. J Cell Sci 2012; 125:2709-2720. 6 
28. Donker RB, Mouillet JF, Chu T, Hubel CA, Stolz DB, Morelli AE, et al. The expression 7 
profile of C19MC microRNAs in primary human trophoblast cells and exosomes. Mol 8 
Hum Reprod 2012; 18:417-424. 9 
29. Peters J. The role of genomic imprinting in biology and disease: an expanding view. Nat 10 
Rev Genet 2014; 15:517-530. 11 
30. Martorell R, and Zongrone A. Intergenerational influences on child growth and 12 
undernutrition. Paediatr Perinat Epidemiol 2012; 26 Suppl 1:302-314. 13 
31. Lango Allen H, Estrada K, Lettre G, Berndt SI, Weedon MN, Rivadeneira F, et al. 14 
Hundreds of variants clustered in genomic loci and biological pathways affect human 15 
height. Nature 2010; 467:832-838. 16 
32. Locke AE, Kahali B, Berndt SI, Justice AE, Pers TH, Day FR, et al. Genetic studies of body 17 
mass index yield new insights for obesity biology. Nature 2015; 518:197-206. 18 
33. Harvey NC, Poole JR, Javaid MK, Dennison EM, Robinson S, Inskip HM, et al. Parental 19 
determinants of neonatal body composition. J Clin Endocrinol Metab 2007; 92:523-20 
526. 21 
34. Addo OY, Stein AD, Fall CH, Gigante DP, Guntupalli AM, Horta BL, et al. Maternal height 22 
and child growth patterns. J Pediatr 2013; 163:549-554. 23 
24 
 
35. Thame M, Osmond C, and Trotman H. Fetal growth and birth size is associated with 1 
maternal anthropometry and body composition. Matern Child Nutr 2015; 11:574-582. 2 
36. Borengasser SJ, Zhong Y, Kang P, Lindsey F, Ronis MJ, Badger TM, et al. Maternal 3 
obesity enhances white adipose tissue differentiation and alters genome-scale DNA 4 
methylation in male rat offspring. Endocrinology 2013; 154:4113-4125. 5 
37. Cooper WN, Khulan B, Owens S, Elks CE, Seidel V, Prentice AM, et al. DNA methylation 6 
profiling at imprinted loci after periconceptional micronutrient supplementation in 7 
humans: results of a pilot randomized controlled trial. FASEB J 2012; 26:1782-1790. 8 
38. Azzi S, Sas TC, Koudou Y, Le Bouc Y, Souberbielle JC, Dargent-Molina P, et al. Degree of 9 
methylation of ZAC1 (PLAGL1) is associated with prenatal and post-natal growth in 10 
healthy infants of the EDEN mother child cohort. Epigenetics 2014; 9:338-345. 11 
39. Steegers-Theunissen RP, Obermann-Borst SA, Kremer D, Lindemans J, Siebel C, 12 
Steegers EA, et al. Periconceptional maternal folic acid use of 400 microg per day is 13 
related to increased methylation of the IGF2 gene in the very young child. PLoS One 14 
2009; 4:e7845. 15 
40. Heijmans BT, Tobi EW, Stein AD, Putter H, Blauw GJ, Susser ES, et al. Persistent 16 
epigenetic differences associated with prenatal exposure to famine in humans. Proc 17 
Natl Acad Sci U S A 2008; 105:17046-17049. 18 
41. Cassidy FC, and Charalambous M. Genomic imprinting, growth and maternal-fetal 19 
interactions. J Exp Biol 2018; 221. 20 
42. Ivanova E, Chen JH, Segonds-Pichon A, Ozanne SE, and Kelsey G. DNA methylation at 21 
differentially methylated regions of imprinted genes is resistant to developmental 22 
programming by maternal nutrition. Epigenetics 2012; 7:1200-1210. 23 
25 
 
43. Radford EJ, Isganaitis E, Jimenez-Chillaron J, Schroeder J, Molla M, Andrews S, et al. An 1 
unbiased assessment of the role of imprinted genes in an intergenerational model of 2 
developmental programming. PLoS Genet 2012; 8:e1002605. 3 
44. Kelsey G, and Feil R. New insights into establishment and maintenance of DNA 4 
methylation imprints in mammals. Philos Trans R Soc Lond B Biol Sci 2013; 5 
368:20110336. 6 
45. Meaburn EL, Schalkwyk LC, and Mill J. Allele-specific methylation in the human 7 
genome: implications for genetic studies of complex disease. Epigenetics 2010; 5:578-8 
582. 9 
46. Tycko B. Allele-specific DNA methylation: beyond imprinting. Hum Mol Genet 2010; 10 
19:R210-220. 11 
47. Voisin S, Almen MS, Zheleznyakova GY, Lundberg L, Zarei S, Castillo S, et al. Many 12 
obesity-associated SNPs strongly associate with DNA methylation changes at proximal 13 
promoters and enhancers. Genome Med 2015; 7:103. 14 
48. Chang G, Mouillet JF, Mishima T, Chu T, Sadovsky E, Coyne CB, et al. Expression and 15 
trafficking of placental microRNAs at the feto-maternal interface. FASEB J 2017; 16 
31:2760-2770. 17 
49. Lin S, Cheung WK, Chen S, Lu G, Wang Z, Xie D, et al. Computational identification and 18 
characterization of primate-specific microRNAs in human genome. Comput Biol Chem 19 
2010; 34:232-241. 20 
50. Nguyen PN, Huang CJ, Sugii S, Cheong SK, and Choo KB. Selective activation of miRNAs 21 
of the primate-specific chromosome 19 miRNA cluster (C19MC) in cancer and stem 22 
cells and possible contribution to regulation of apoptosis. J Biomed Sci 2017; 24:20. 23 
26 
 
51. Nguyen PNN, Choo KB, Huang CJ, Sugii S, Cheong SK, and Kamarul T. miR-524-5p of the 1 
primate-specific C19MC miRNA cluster targets TP53IPN1- and EMT-associated genes to 2 
regulate cellular reprogramming. Stem Cell Res Ther 2017; 8:214. 3 
 4 
5 
27 
 
FIGURE LEGENDS 1 
 2 
Figure 1. Higher maternal size correlated with lower C19MC methylation in placenta. (A) 3 
Scatter plot of pre-gestational maternal weight and C19MC ICR mean methylation. (B) Scatter 4 
plot of maternal height and C19MC ICR mean methylation. (C) Scatter plot of pre-delivery 5 
maternal weight and C19MC ICR mean methylation. Pearson correlation statistics are shown 6 
within each box. 7 
 8 
Figure 2. Lower placental C19MC ICR methylation associated with greater offspring’s size 9 
and adiposity at 6 years of age. Scatter plots showing the correlation of placental C19MC ICR 10 
methylation levels with offspring’s weight z-score (A), height z-score (B), waist circumference 11 
(C), hip circumference (D), fat mass (E) and visceral fat volume (F) at 6 years of age. Pearson 12 
correlation statistics are shown in the boxes. 13 
 14 
Figure 3. Placental methylation levels at the C19MC ICR and gene expression. Scatter plot 15 
showing the correlation of placental C19MC ICR methylation levels with median C19MC gene 16 
expression (n=56). Pearson correlation statistics are shown in the box. 17 
 18 
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REVIEWER’S COMMENTS 1 
Associate Editor (Comments to the Author):  2 
Please change the term "gender" (societal role) to "sex" if biologic category is being defined.  3 
“Gender” has been replaced by “sex” throughout the manuscript and tables/figures as it 4 
defines a biologic category. 5 
 6 
Reviewer #1 (Comments to the Author):  7 
In this study Prats-Puig et al describe a series of studies looking at the methylation of the 8 
C19MC in the placenta and the association of this methylation with body size and composition 9 
of the child at birth and 6 years of age as well as in the body size of the parents. They quantify 10 
DNA methylation of 5 CpGs in the ICR for the cluster and show that the methylation of these 11 
CpGs is concordant. They then show that methylation of the ICR is inversely associated with 12 
maternal size but there are no associations with paternal size. Comparison of the methylation 13 
of the ICR with offspring phenotype did not show any associations with birth measurements 14 
but did show associations with the anthropomorphic measurements in the subset analysed at 15 
6 years of age.  16 
Overall, I think that this is a nice study that is clearly presented. My major criticism is based 17 
around the question of whether it is possible to quantify the expression of at least one of the 18 
C19MC miRNAs in the placental tissue that has been collected. This is not to look at the 19 
expression in fetal tissues which obviously can’t be done for the individuals included in this 20 
study (and which the authors say is beyond the scope of this study). The reason for this is that 21 
it would give them a more direct link to this set of miRNAs rather than other genes in this 22 
locus that are paternally expressed. It would also confirm that methylation of this locus is 23 
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linked to expression levels of the miRNA (at least in the placenta). Obviously it can only be 1 
done if the samples are available in a suitable format.  2 
We agree with the reviewer’s point. In order to address this issue, we have quantified the 3 
expression levels of representative miRNAs (miR-517a, miR-517c, miR-520c and miR-520g) in 4 
56 cases with available placental samples. These miRNAs have been chosen in order to have a 5 
wide coverage within the cluster and a wide range of expression levels (high, medium, low) 6 
according to previous data [Donker RB et al. The expression profile of C19MC microRNAs in 7 
primary human trophoblast cells and exosomes. Mol Hum Reprod 2012 Aug 28(8) 417-424]. 8 
Due to the complexity of this locus, which is transcribed as a single pri-miRNA and post-9 
transcriptionally processed to generate numerous miRNAs [Bellemer CJ et al. Microprocessor 10 
dynamics and interactions at endogenous imprinted C19MC microRNA genes. Cell Sci. 2012 11 
Jun 1;125(Pt 11):2709-20], we calculated the median expression of the 4 analyzed miRNAs in 12 
order to estimate the global gene expression of C19MC.  13 
In a bivariate correlation analysis, C19MC ICR methylation levels associated with median 14 
miRNA expression (r= ‒0.267, p=0.047; Figure 3). 15 
 16 
 17 
 18 
 19 
 20 
 21 
 22 
 23 
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 1 
 2 
According to this, the manuscript has been mainly modified as follows: 3 
MATERIALS AND METHODS: 4 
“Gene expression by Real Time-PCR 5 
Total RNA was extracted and retrotranscribed using the RNeasy mini kit (Qiagen) and the 6 
Megaplex Human RT Primers (Pool A v2.1) with MultiScribe Reverse Transcriptase 7 
(Thermofisher Scientific, Waltham, MA). The following TaqMan Gene Expression assays 8 
(Thermofisher Scientific) were used to amplify the cDNA: miR-517a (Ref#002402), miR-517c 9 
(Ref#001153), miR-520c (Ref#002389), miR-520g (Ref#001121) and the endogenous controls 10 
miR-523 (Ref#002386), miR-532 (Ref#001518) and miR-425-5p0 (Ref#425-5p).26 Reactions 11 
were run on a LightCycler 480 Real-Time PCR System (Roche Diagnostics, Rotkreuz, 12 
Switzerland), using the default cycling conditions. Relative mRNA levels were calculated 13 
according to the 2–ΔCT method.” 14 
RESULTS: 15 
“Placental C19MC ICR methylation levels and gene expression 16 
Finally, we investigated the potential link between C19MC ICR methylation and gene 17 
expression, both in placental samples. Due to the complexity of this locus, which is transcribed 18 
as a single pri-miRNA and post-transcriptionally processed to generate numerous miRNAs with 19 
a wide range of expression levels,27, 28 we quantified the gene expression of representative 20 
miRNAs (miR-517a, miR-517c, miR-520c and miR-520g) in 56 placental samples. These miRNAs 21 
were chosen in order to have diverse expression levels (high, medium, low) and wide coverage 22 
within the cluster. Median expression of the 4 analyzed miRNAs was used in order to estimate 23 
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the global gene expression of C19MC. In a bivariate correlation analysis, C19MC ICR 1 
methylation levels associated with median miRNA expression (r= ‒0.267, p=0.047; Figure 3).” 2 
My other man point is that the associations at 6 years are from a sub-population of the whole 3 
study and indicate either a difference between the effects of the miRNAs at the two ages or 4 
the steady accumulation of effect until it is large enough to measure. However, it is also 5 
possible that it is an artefact of the subgroup. I accept that there is no difference in the 6 
birthweight of those who did or did not come back for the follow-up but it would be useful to 7 
confirm that there is no association of the methylation status with birthweight 8 
anthropomorphic measurements in the 32 individuals that form the 6 year old group. If such 9 
an association did exist in the subgroup it would complicate the interpretation of the data.  10 
Regarding the reviewer’s comment, we have studied the association of birth weight/height 11 
and methylation in the subpopulation with follow-up (n=32). 12 
The associations have been adjusted for maternal/paternal height or weight in multiple 13 
regression analyses. As shown in the table below, C19MC ICR methylation was not associated 14 
with either sex- and gestational age-adjusted birth weight (Birth weight z-score) or height z-15 
score significantly associated with in the subpopulation with follow-up. 16 
Table 1. Multivariate linear models of placental C19MC ICR methylation levels and birth 
weight/height in the follow-up subpopulation (n=32). 
 β p Total R2 
Birth weight z-score    0.18 
C19MC ICR mean methylation (%) -0.180 0.341  
Maternal weight (Kg) 0.203 0.313  
Paternal weight (Kg) 0.453 0.015*  
Birth height z-score   0.33 
C19MC ICR mean methylation (%) -0.231 0.145  
Maternal height (cm) 0.133 0.443  
Paternal height (cm) 0.592 0.001***  
 17 
 18 
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 1 
Reviewer #2 (Comments to the Author):  2 
This paper by Prats-Puig et al, investigate the methylation of the human placental-specific 3 
imprinted miRNA cluster C19MC in links with body size in the mother and child.  4 
The analysis is focused on the methylation status of 5 CpG located in the Imprinted Control 5 
Region of C19MC, evaluated by pyrosequencing. The authors show a series of negative 6 
correlation between the placental methylation and maternal body parameters, a link between 7 
paternal allelic transmission and methylation level. Lower methylation is associated to 8 
increased offspring size and weight at 6 years.  9 
These results are interesting and novel, especially the follow-up of the offspring. The paper is 10 
well written and balanced.  11 
I have some minor remarks and questions:  12 
 13 
1. Table 1 should be presented as part of the material and methods instead as in the results.  14 
According to the reviewer’s suggestions, we have presented Table 1 in the material and 15 
methods section: 16 
“Study population and ethics 17 
The study population included 72 pregnant Caucasian women delivering healthy infants, and 18 
63 of the respective fathers who also accepted to participate in this longitudinal cohort study 19 
(Table 1).” 20 
 21 
2. Is there an effect of the parity on methylation of the ICR? Even if it is not possible to have a 22 
longitudinal analysis (i.e. several children from the same mother) it may be evaluate globally 23 
on the various samples. In the same order of ideas, are there samples from dizygotic twins; in 24 
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this case how is the methylation of the placentas? What is the link with the growth later, if 1 
here are some samples of this kind in the collection?  2 
Regarding the reviewer’s point, we have studied whether parity influences C19MC ICR 3 
methylation levels. As shown in the table below, parity does not influence C19MC ICR 4 
methylation levels in the placenta. 5 
Table 2. Effect of parity on C19MC ICR methylation levels. 
Parity C19MC methylation (%) 
Student’s T test 
p-value 
Primiparous (n=41) 42.4 ± 8.0 0.583 
Multiparous (n=31) 43.4 ± 8.0  
  6 
Regarding the other points raised by the reviewer, twin pregnancies were excluded in our 7 
study and therefore we cannot provide relevant information to his/her comment. 8 
 9 
3. Given the effects found by the authors, would not it be nice to incorporate a discussion in 10 
relation with the different papers that identify gene variants linked to height and that explain 11 
only very partly the existing variation such as Lango Allen et al (Nature 2010)  12 
Following the reviewer’s suggestions, we have included this information in the discussion 13 
section: 14 
“In our study, methylation at placental C19MC ICR associates with offspring’s anthropometry 15 
independently of maternal weight and height, and thus the association found in our cohort 16 
between maternal weight/height and offspring’s weight/height may be explained at least 17 
partially by placental C19MC ICR methylation. Our results therefore suggest that besides 18 
genetic factors,29 the offspring’s size may be also modulated by epigenetic factors at early 19 
stages of life. Not surprisingly, Genome-Wide Association Studies have identified gene variants 20 
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associated with height or BMI that are only able to explain around 20% of the heritable 1 
variation.30, 31” 2 
3 
36 
 
METHYLATION OF THE C19MC microRNA LOCUS IN THE PLACENTA: ASSOCIATION WITH 1 
MATERNAL AND CHILHOOD BODY SIZE 2 
 3 
Anna PRATS-PUIG1,2*; Sílvia XARGAY-TORRENT1*; Gemma CARRERAS-BADOSA1; Berta MAS-4 
PARÉS1; Judit BASSOLS1; Clive J PETRY3; Michael GIRARDOT4; Francis DE ZEGHER5; Lourdes 5 
IBÁÑEZ6,7; David B DUNGER3; Robert FEIL4#; Abel LÓPEZ-BERMEJO1,8# 6 
 7 
1
Department of Pediatrics, Girona Institute for Biomedical Research (IDIBGI), Salt, Spain  8 
2
Department of Physical Therapy, EUSES University of Girona, Spain 9 
3
Department of Paediatrics, University of Cambridge, Cambridge, United Kingdom 10 
4
Institute of Molecular Genetics (IGMM), CNRS, University of Montpellier, Montpellier, France 11 
5
Department of Development & Regeneration, University of Leuven, Leuven, Belgium 12 
6
Endocrinology, Institut de Recerca Pediàtrica Sant Joan de Déu, University of Barcelona, Esplugues, Spain 13 
7
Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), 14 
ISCIII, Madrid, Spain 15 
8
Department of Pediatrics, Dr. Josep Trueta Hospital, Girona, Spain 16 
*These authors are co-first authors and contributed equally to this work. 17 
#These authors are co-senior authors and contributed equally to this work. 18 
 19 
Running title: C19MC methylation and offspring’s size 20 
 21 
Correspondence: Abel López-Bermejo, MD, PhD; Pediatric Endocrinology, Institut 22 
d'Investigació Biomèdica de Girona Dr. Josep Trueta (IDIBGI), Edifici Hospital Dr. Josep Trueta, 23 
Av. de França, s/n, 17007 Girona. Spain. Tel: 00 (+34) 972 940 200 (Ext. 2810), 24 
alopezbermejo@idibgi.org. 25 
 26 
 27 
Word count: Abstract 219; Main Text 3575; 2 Tables and 3 Figures, 8 Supplementary Tables 28 
and Figures.  29 
30 
37 
 
ABSTRACT 1 
Objectives: To study DNA methylation at the C19MC locus in the placenta and its association 2 
with: 1) parental body size, 2) transmission of haplotypes for the C19MC rs55765443 SNP, 3) 3 
offspring’s body size and/or body composition at birth and in childhood.  4 
Subjects and methods: Seventy-two pregnant women-infant pairs and 63 fathers were 5 
included in the study. Weight and height of mothers, fathers and newborns were registered 6 
during pregnancy or at birth (n=72). Placental DNA methylation at the C19MC imprinting 7 
control region (ICR) was quantified by bisulfite pyrosequencing. Genotyping of the SNP was 8 
performed using restriction fragment length polymorphisms. The children’s body size and 9 
composition were reassessed at age 6 years (n=32). 10 
Results: Lower levels of placental C19MC methylation were associated with increased body 11 
size of mother, specifically with higher pre-gestational and pre-delivery weights and height of 12 
the mother (β from –0.294 to –0.371; R2 from 0.04 to 0.10 and all p<0.019), and with higher 13 
weight, height, waist and hip circumferences, and fat mass of the child (β from –0.428 to –14 
0.552; R2 from 0.33 to 0.56 and all p<0.009). Parental transmission of the SNP did not 15 
correlate with an altered placental methylation status at the C19MC ICR.  16 
Conclusions: Increased maternal size is associated with reduced placental C19MC 17 
methylation, which, in turn, relate to larger body size of the child. 18 
 19 
Keywords: maternal size, DNA methylation, programming, rs55765443. 20 
 21 
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INTRODUCTION 1 
Genomic imprinting is a complex epigenetically-regulated phenomenon by which some 2 
genes become mono-allelically expressed in a parent-of-origin specific manner.1, 2 Imprinted 3 
genes play essential roles in prenatal growth of the embryo and/or placenta functions.3-6  4 
In the human placenta, the chromosome 19 microRNA cluster (C19MC) is imprinted, 5 
and is expressed exclusively from the paternally inherited allele as confirmed by the 6 
genotyping of a single nucleotide polymorphism (SNP: G or T, rs55765443) mapping upstream 7 
the most-5’ microRNA transcribed by C19MC.7 This primate-specific microRNA cluster spans 8 
∼100 kb and produces 56 mature microRNAs.8, 9 The cluster is governed by the DNA 9 
methylation status of an imprinting control region (ICR) located about 17.6 kb upstream the 10 
microRNA cluster.7, 10 C19MC, which is expressed almost exclusively in placenta,11 is believed 11 
to play important roles in the regulation of cellular differentiation, trophoblast migration and 12 
immunomodulation during pregnancy.12, 13 Altered expression of C19MC has been reported in 13 
gestational hypertension, preeclampsia and fetal growth restriction.12, 13  14 
Fetal growth and postnatal development, which are critical processes of life, are 15 
regulated by genetic and epigenetic factors. SNPs located within or in the vicinity of imprinted 16 
genes correlate with fetal growth characteristics in a parent-of-origin manner.14, 15 Non-17 
genetic variation or pathological disruption of DNA methylation marks in several imprinted 18 
loci, including  IGF2-H19, GNAS or DLK1-DIO3, have been consistently related to changes in 19 
pre- and postnatal growth as well.16-19 20 
Currently, there are no reports of parental factors related to placental C19MC 21 
methylation variation, nor about the impact of C19MC differential methylation on the 22 
offspring’s development. Here, we examined for the first time the placental C19MC DNA 23 
methylation levels and their association with 1) parental weight and height, 2) parental 24 
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transmission of haplotypes within a SNP (rs55765443) in C19MC, 3) postnatal growth and 1 
body composition of the offspring at birth and in childhood, and 4) gene expression levels of 2 
representative C19MC miRNAs. 3 
 4 
5 
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METHODS 1 
 2 
Study population and ethics 3 
The study population included 72 pregnant Caucasian women who delivered healthy 4 
infants, and 63 of the respective fathers who also accepted to participate in this longitudinal 5 
cohort study (Table 1). The subjects were recruited during the first trimester of pregnancy 6 
among those seen within a setting of prenatal primary care in l’Alt Empordà and Girona 7 
(North-eastern Spain) from 2008 to 2010. Information on pregnancy, labor and delivery 8 
characteristics was retrieved from standardized medical records. Pregnancies resulting from 9 
assisted reproductive technology (ART) were excluded because ART may perturb imprinting.20 10 
Women with major medical, surgical or obstetrical complications, including multiple 11 
pregnancies, hypertension, gestational diabetes or preeclampsia, and fetal growth restriction, 12 
malformations or asphyxia were also excluded.  13 
The protocol was approved by the Institutional Review Board of Dr. Josep Trueta 14 
Hospital (Reference number: 2013132; Approval date: November 24th 2014) and informed 15 
written consent was obtained from all parents.  16 
 17 
Anthropometric assessments 18 
Father’s weight and height were measured at inclusion without shoes and wearing 19 
light clothes; maternal weight and height were assessed similarly at each trimester of 20 
gestation. Body-mass index (BMI) was calculated as weight divided by height squared (Kg/m2).  21 
All infants were born at term of pregnancy. After delivery, weight and length were 22 
measured using a calibrated scale and a measuring board. Gestational age- and sex-adjusted 23 
z-scores for birth weight and length were calculated using regional norms.21 From the children 24 
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included at birth, those whose parents agreed that they could participate further in the study 1 
(n=32) were followed-up at the age of 6 years. Their characteristics at birth did not differ from 2 
those who did not participate in the follow-up study. Weight was measured on a calibrated 3 
scale wearing light clothes, and height was measured with a Harpenden stadiometer without 4 
shoes. BMI and age- and sex-adjusted z-scores were calculated as above. Waist circumference 5 
was measured in the supine position at the umbilical level. Hip circumference was measured 6 
at the widest part, at the level of the greater trochanters. 7 
Fat measurements  8 
Fat mass was assessed by bioelectric impedance (Hydra Bioimpedance Analyzer 4200; 9 
Xitron Technologies, San Diego CA), at the age of 6 years, as previously described in 10 
prepubertal children.22  11 
Visceral fat was estimated as described by Hirooka et al23 using high-resolution 12 
ultrasonography (MyLabTM25, Esaote, Italy) in a transverse abdominal scan with a convex 3-13 
3.5 MHz transducer, with minimal pressure applied to prevent compression of the fat layers. 14 
Measurement of visceral fat by ultrasound correlates well with that measured by computed 15 
tomography.23, 24 All images were obtained with the subject in supine position at the end of a 16 
normal exhalation and performed by the same observer. The average of three measurements 17 
was used for all sites; the intra-subject coefficient of variation was <6%.  18 
 19 
Sample collection 20 
Blood samples were drawn from both progenitors in EDTA tubes at the initial visit. 21 
Samples were centrifuged at 2000 x g for 15 minutes at 4ºC and total leukocytes were 22 
harvested. The placentas were collected immediately after childbirth. Three cuboidal biopsies 23 
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(1 cm3) containing placental villous tissue, were dissected from the non-membranous surface 1 
(maternal side) of placentas after removing the decidua (outermost layer) midway between 2 
the umbilical cord and the placental margin. The same location was used when sampling all 3 
placentas to reduce interplacental variability. All samples were stored at -80ºC.  4 
 5 
DNA methylation analysis  6 
Quantitative DNA methylation analysis was performed by pyrosequencing of 7 
bisulphite-treated DNA.25 Genomic DNA was extracted from placentas using the Gentra 8 
PureGene tissue kit (Qiagen, Germany). Sodium bisulfite conversion of 500 ng of DNA was 9 
performed using the EZ DNA Methylation-Gold kit (Zymo Research, Irvine CA). Bisulphite-10 
treated DNA (20 ng) was amplified with 0.3 µM of forward and biotinylated reverse primers 11 
(Supplementary Table S1). Reactions were performed in 1X Taq GOLD buffer adjusted to 12 
1.5 mM MgCl2, 0.2 mM dNTPs and 1 U of Taq GOLD polymerase (Qiagen) in a total volume of 13 
35 µl. PCR cycling steps were: 15 min at 94°C followed by 40 cycles of 20 s at 94°C, 30 s at 14 
58.6ºC and 1 min at 72°C, with a final extension of 10 min at 72°C. PCR product was rendered 15 
single-stranded25 and 4 pmol of the sequencing primer (Supplementary Table S1) were added 16 
following pyrosequencing in PyroMark Q96 ID and Q96 MD instruments (Qiagen). Raw data 17 
were analyzed using the Q-CpG software (V.1.0.9, Biotage AB), which calculates the ratio of 18 
converted Cs (Ts) to unconverted Cs at each CpG, giving the percentage of methylation. All 19 
reactions were run in duplicates. We analyzed 5 consecutive CpG dinucleotides located within 20 
the C19MC ICR (chr19:53648001-53648160 from UCSC Genome Browser, Human Dec. 2013 21 
(GRCh38/hg38) Assembly, Supplementary Figure S1A). The overall DNA methylation level 22 
across the C19MC ICR was defined as the average of methylation at all 5 CpG sites.  23 
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Genotyping (Restriction Fragment Length Polymorphisms, RFLPs) 1 
Mother-father-child trios were genotyped in order to study the paternal and maternal 2 
transmission of rs55765443 SNP alleles to the child. To assess parental genotype, DNA was 3 
extracted from parental blood leukocytes using the Gentra PureGene blood kit (Qiagen). For 4 
fetal genotyping, DNA was extracted from placentas as described above. DNA (10 ng) was 5 
amplified in a 10 µl reaction with 1x NH4 buffer supplemented with 1.5 mM MgCl2, 0.2 mM 6 
dNTPs, 0.5 U BIOTAQ DNA Polymerase (Bioline, Memphis TN) and 0.6 pmol/µl of each primer. 7 
PCR primers (chr19:53665044; UCSC Genome Browser, Human Dec. 2013 (GRCh38/hg38) 8 
Assembly) were: forward 5’-TGTGGCCAGACTTTAATCCA-3’ and reverse 5’-9 
TTGGAGATTTTAGGGGGAGTC-3’. PCR conditions were: 94ºC for 5 min; 20 cycles of 94ºC 45 s, 10 
64ºC 45 s (decreasing 0.5ºC each cycle) and 72ºC 45s; 15 cycles of 94ºC 45 s, 54ºC 45 s and 11 
72ºC 45s; and 72ºC for 10 min. PCR product (207 bp) was then digested with 1 U of BsoBI 12 
restriction enzyme (New England Biolabs, Ipswich Massachusetts) at 37ºC for 16 hours. The 13 
fragments were visualized by electrophoresis through a 2% (w/v) agarose gel. The different 14 
genotypes were assessed according to the size and pattern of distribution of the fragments 15 
(Homozygous T: 1 band 207 bp; Heterozygous: 3 bands of 207, 152 and 55 bp; Homozygous G: 16 
2 bands of 152 and 55 bp). Mother-father-child trios that were all heterozygous were 17 
uninformative for imputing parental allelic transmission, thus the final number of samples 18 
used in the analysis was 53 trios. All SNP genotypes were shown to be consistent with Hardy–19 
Weinberg equilibrium (χ2 test p=0.900). 20 
 21 
Gene expression analysis by Real Time-PCR 22 
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Total RNA was extracted and retrotranscribed using the RNeasy mini kit (Qiagen) and the 1 
Megaplex Human RT Primers (Pool A v2.1) with MultiScribe Reverse Transcriptase 2 
(Thermofisher Scientific, Waltham, MA). The following TaqMan Gene Expression assays 3 
(Thermofisher Scientific) were used to amplify the cDNA: miR-517a (Ref#002402), miR-517c 4 
(Ref#001153), miR-520c (Ref#002389), miR-520g (Ref#001121) and the endogenous controls 5 
miR-523 (Ref#002386), miR-532 (Ref#001518) and miR-425-5p0 (Ref#425-5p).26 Reactions 6 
were run on a LightCycler 480 Real-Time PCR System (Roche Diagnostics, Rotkreuz, 7 
Switzerland), using the default cycling conditions. Relative mRNA levels were calculated 8 
according to the 2–ΔCT method. 9 
Statistics 10 
Statistical analyses were performed using the SPSS 22.0 package (SPSS Inc). Non-11 
normally distributed data was log-transformed to improve symmetry. The relationship 12 
between DNA methylation levels and both anthropometric parameters and gene expression 13 
was tested by Pearson correlation followed by multiple regression analysis using the enter 14 
method to adjust for possible confounding variables (maternal pre-gestational and gestational 15 
weight, maternal height, gestational age, birth weight or length, and child’s sex, age and BMI). 16 
Differences in DNA methylation levels among haplotypes were examined by unpaired 17 
Student’s T-test. Accepting an alpha risk of 0.05 in a bilateral contrast, the study has an 80% 18 
power to detect a significant Pearson correlation coefficient of at least 0.5 between variables, 19 
and a difference of at least 5 units in DNA methylation between groups assuming a standard 20 
deviation (SD) of 5 units (GRANMO, IMIM, version 7.12). When analyzing the percentage of 21 
methylation of each CpG, the statistical significance was set at 0.0125 after applying the 22 
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Bonferroni correction for subgroup analyses (0.05/4 subgroup analyses: maternal 1 
characteristics, paternal characteristics, data at birth and childhood data). 2 
3 
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RESULTS  1 
Subjects 2 
Table 1 shows the clinical variables in the parents and their children, at birth and at 6 3 
years of age. Maternal anthropometric variables (height, pre-gestational and predelivery 4 
weights, and pregestational BMI) associated with offspring’s variables (weight, height and 5 
BMI) at birth and 6 years of age (Supplementary Table S2).  6 
 7 
DNA Methylation levels at C19MC in placental tissue 8 
DNA methylation levels of the 5 studied CpGs within the ICR region of C19MC 9 
(Supplementary Figure S1A) were assessed by pyrosequencing. The percentage of DNA 10 
methylation in placenta for each CpG and the average methylation for all CpGs are shown in 11 
Supplementary Figure S1B. Average methylation levels of the combined CpGs at C19MC ICR 12 
ranged from 26 to 56% with mean and SD values of 42.7 ± 7.9 %. The methylation levels at the 13 
different CpGs analyzed were highly concordant. This indicates that methylation was affected 14 
similarly across the entire genomic region. 15 
 16 
Higher maternal size correlates with lower C19MC methylation in the placenta 17 
Firstly, we aimed to study the relationship between methylation levels at the C19MC 18 
ICR and parental phenotype. Higher maternal pre-gestational weight (r=–0.316, p=0.007), 19 
height (r=–0.291, p=0.013) and BMI (r=–0.237, p=0.045), as well as pre-delivery weight (r=–20 
0.376, p=0.002), associated with lower mean methylation levels at the placental C19MC ICR 21 
(Figure 1 A-C and Supplementary Table S3). Paternal anthropometric variables were not 22 
related to methylation levels within the placental C19MC cluster (Supplementary Table S3).  23 
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Following correction for multiple testing, maternal pre-gestational weight, height and pre-1 
delivery weight remained significantly associated with mean methylation at C19MC ICR (all 2 
p≤0.01). Maternal pre-gestational weight (p=0.011), height (p=0.019) and pre-delivery weight 3 
(p=0.003) independently explained mean placental C19MC methylation levels in multivariate 4 
linear models after adjusting for the following confounding variables: maternal age, 5 
gestational age and child’s sex, with model R2 of 0.05, 0.04 and 0.10, respectively 6 
(Supplementary Table S4).  7 
 8 
Parentally transmitted alleles for the rs55765443 SNP and placental C19MC DNA methylation  9 
We further assessed whether placental C19MC ICR methylation levels were related to 10 
the parental transmission of the rs55765443 SNP within the C19MC cluster. Maternally 11 
transmitted haplotypes had no significant effect on placental C19MC methylation levels 12 
(Supplementary Figure S2A and Table S5).  13 
Fetal inheritance of the paternal T allele was associated with lower methylation levels 14 
(39.8 ± 2.0 %) when compared with the G allele (47.2 ± 2.0 %) only at CpG5 of C19MC ICR 15 
(p=0.05, Supplementary Table S5). As for mean C19MC ICR methylation levels, the difference 16 
between T (41.0 ± 1.4 %) and G alleles (45.3 ± 1.6 %, Supplementary Figure 2B and Table S5) 17 
approached significance (p=0.059). However, none of these associations remained significant 18 
after correction for multiple testing. 19 
 20 
Lower placental C19MC methylation levels associates with bigger offspring’s size at 6 years of 21 
age 22 
Next, we examined the consequences of the differential DNA methylation at the 23 
placental C19MC ICR on the offspring at birth and at age 6 years. At birth, no statistically 24 
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significant relationships between newborns’ anthropometric variables and C19MC 1 
methylation levels were observed (Supplementary Table S6). However, lower mean 2 
methylation levels at placental C19MC ICR correlated with larger children’s size and fat 3 
abundance at age 6 years [weight (p≤0.001), height (p=0.001), BMI (p=0.017), waist (p=0.003), 4 
hip (p=0.003), fat mass (p=0.005) and visceral fat (p=0.009); Figure 2 and Supplementary Table 5 
S6].  6 
The correlations between methylation at C19MC ICR and weight, height, waist 7 
circumference, hip circumference, fat mass or visceral fat in the offspring remained significant 8 
after correction for multiple testing (all p≤0.0125). Placental C19MC ICR methylation levels 9 
also remained independently associated with children’s anthropometric variables (weight, 10 
height, waist and hip) after adjusting for confounding variables, including maternal weight or 11 
height, in general linear models (Table 2). The association of C19MC ICR methylation with fat 12 
mass, but not that with visceral fat, was also independent of confounding variables (Table 2).  13 
 14 
Placental C19MC ICR methylation levels and gene expression 15 
Finally, we investigated the potential link between C19MC ICR methylation and gene 16 
expression in the placental samples. Due to the complexity of this locus, which is transcribed 17 
as a single pri-miRNA and post-transcriptionally processed to generate numerous miRNAs 18 
with a wide range of expression levels,27, 28 we quantified the expression of representative 19 
miRNAs (miR-517a, miR-517c, miR-520c and miR-520g) in 56 placental samples. These miRNAs 20 
were chosen in order to have diverse expression levels (high, medium, low) and a wide 21 
coverage across the cluster. Median expression of the 4 analyzed miRNAs was used in order to 22 
approximate the gene expression levels of C19MC. In a bivariate correlation analysis, 23 
increased C19MC ICR methylation associated with reduced median miRNA expression (r= 24 
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‒0.267, p=0.047; Figure 3). This finding suggests that ICR methylation negatively affects 1 
miRNA expression across the locus.  2 
3 
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DISCUSSION 1 
Although altered expression of imprinted gene clusters has been linked to postnatal 2 
growth disorders,29 evidence that the placental imprinted C19MC cluster may play a role in 3 
this process is missing. Here, we show for the first time that, in the placenta, the level of 4 
methylation at the C19MC ICR is linked to maternal weight and height, and is ultimately 5 
related to the offspring’s body size and body composition in childhood.  6 
Interestingly, placental C19MC ICR methylation associated with the offspring’s 7 
anthropometry, independently of maternal weight and height. The association found in our 8 
cohort, between maternal weight/height and offspring’s weight/height, may be explained at 9 
least partially by placental C19MC ICR methylation levels. Thus, besides genetic factors,30 the 10 
offspring’s size may be significantly modulated by epigenetic factors at early stages of life. 11 
More generally, and in agreement with our finding, gene variants associated with height or 12 
BMI have been found to account for only around 20% of the heritable phenotypic variation.31, 13 
32  14 
Different studies have shown that maternal size correlates with the offspring’s growth 15 
and body composition.33-35 Our results suggest a possible role for placental C19MC ICR 16 
methylation in the modulation of childhood growth. Similarly, placental DNA methylation at 17 
the IGF2-H19, GNAS and DLK1-DIO3 imprinted loci has been linked to pre and postnatal 18 
growth characteristics.16, 18, 19 Moreover, our results link placental C19MC ICR methylation to 19 
the body composition of the offspring in childhood. Interestingly, maternal obesity has been 20 
suggested to alter adipocyte commitment and differentiation in the offspring via an 21 
epigenetic mechanism as well.36 Our findings suggest that maternal size and offspring fat mass 22 
at 6 years of age may, at least in part, be linked to C19MC methylation.  23 
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It has been shown that maternal factors, such as nutrient supplementation or alcohol 1 
intake, can alter DNA methylation patterns of imprinted genes with paternal expression, for 2 
instance at MEST, PLAGL1 or IGF2.37-40 It is therefore plausible that maternal body weight or 3 
height, may also influence placental methylation as well. In principle, the maternal allele is 4 
virtually 100% methylated at C19MC, as opposed to the paternal allele, which is 0% 5 
methylated. However, we found C19MC ICR global methylation to be less than 50% in most 6 
cases. This suggested that the maternal allele had partially lost its imprinting marks, thus 7 
allowing limited maternal expression and probably leading to functional consequences due to 8 
the high dosage sensitivity of imprinted gene expression.41  9 
In contrast to pre-gestational maternal weight, gestational weight gain cannot be 10 
directly linked to placental C19MC ICR methylation. Indeed, previous studies have suggested 11 
that nutrition throughout gestation does not contribute to the epigenetic reprogramming of 12 
the ICRs of GNAS, GRB10, KCNQ1OT1/CDKN1C and H19/IGF2 loci.42, 43 These findings could be 13 
related to the imprinted condition of the studied gene clusters. DNA methylation at ICRs of 14 
imprinted genes is acquired during gametogenesis, thus establishing germline-derived 15 
differentially methylated regions, and is refractory to the genome-wide methylation 16 
reprogramming that occurs in the embryo after fertilization.20, 29, 44 Accordingly, maternal 17 
weight during oogenesis and early embryogenesis, rather than gestational weight gain, could 18 
affect the DNA methylation at the imprinted C19MC ICR.  19 
DNA methylation levels can also be modified by the presence of specific SNPs.45 SNPs 20 
neighboring CpG islands, such as rs55765443, can lead to allele-specific DNA methylation 21 
changes, usually in a cis-acting mechanism.46 In this line, several obesity-associated SNPs have 22 
been reported to be associated with methylation levels at proximal CpG sites.47 In the C19MC 23 
cluster, the maternal allele is methylated by a specific imprint acquired in oocytes,7 thus it 24 
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would be plausible that a SNP in the maternally transmitted allele could affect C19MC ICR 1 
methylation levels. We therefore studied the relationship of the maternal and paternal alleles 2 
for the rs55765443 SNP with methylation levels. While no association was evident for 3 
transmission of the maternal allele and C19MC ICR methylation levels, we found a tendency 4 
for the paternally transmitted allele to be associated with altered methylation levels, which 5 
was not confirmed in adjusted analyses. We cannot rule out the possibility that other SNPs 6 
located close to this region could be linked to altered methylation levels of the C19MC ICR.  7 
Epigenetic variations at placental C19MC may be associated with concordant levels of 8 
change in gene expression that could explain the observed link between the cluster and 9 
offspring’s anthropometry. In fact, C19MC microRNAs can traffic among placental, maternal 10 
and fetal compartments,48 feasibly influencing fetal programming and thus the developmental 11 
trajectory. Computational and bioinformatic analyses have predicted that C19MC miRNAs 12 
participate in reproduction, development, and differentiation,49 including stem cell self-13 
renewal and pluripotency by controlling G1-S transition and apoptosis signaling.50 Indeed, 14 
members of the C19MC cluster have been shown to regulate cellular reprogramming, 15 
enhance proliferation and suppress apoptosis.51 Regarding our results, a possible hypothesis is 16 
that differential methylation at the C19MC cluster may cause molecular changes in fetal 17 
tissues, probably in stem cells, through variations in microRNAs levels. C19MC microRNAs may 18 
thus target and prime specific fetal tissues, such as adipose tissue, for enhanced proliferation 19 
later in life. This hypothesis could not be tested in our study. Instead, we analyzed the 20 
expression levels of representative C19MC miRNAs in placental tissue and found that 21 
methylation levels in this locus associated with miRNA expression levels. Although the 22 
molecular changes may be rather fast, the anthropometric changes (weight, height or fat 23 
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mass) could need more time to be revealed, and thus they may not be seen until childhood, 1 
explaining the lack of association with infants’ anthropometry.   2 
We acknowledge some study limitations. The specific role for the rs55765443 paternal 3 
haplotype on C19MC methylation, as well as the interaction between the paternally 4 
transmitted allele and maternal size as modifiers of the placental C19MC ICR methylation 5 
levels, need to be addressed in additional studies. A next step should also include the analysis 6 
in fetal tissues of gene expression levels of the 56 microRNAs encoded by C19MC cluster, 7 
which was beyond the scope of the current study. Finally, other factors such as diet or other 8 
environmental factors were not included in the current analysis but should be considered for 9 
further studies as possible confounders.  10 
The strengths of our study include the follow-up data on the offspring. Moreover, due 11 
to the crucial role of imprinted genes in early life development, the significance of our study is 12 
warranted, since elucidating the factors that affect their epigenetic regulation has important 13 
implications for understanding the causes of human health and disease, and may help to 14 
establish protocols for early detection/prevention of adult diseases. Finally, the use of 15 
placenta to predict complications later in life would have obvious advantages, as it is an easily 16 
available tissue that can be sampled non-invasively. 17 
 In summary, maternal size associates with the percentage of methylation within the 18 
placental C19MC ICR, and such methylation levels are related to offspring’s size and body 19 
composition at age 6 years. Increased maternal size may reduce placental C19MC 20 
methylation, in turn leading to larger size of the offspring in childhood. These results may help 21 
to establish protocols for early detection/prevention of childhood/adulthood diseases related 22 
to body size and composition. 23 
 24 
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FIGURE LEGENDS 1 
 2 
Figure 1. Higher maternal size correlated with lower C19MC methylation in placenta. (A) 3 
Scatter plot of pre-gestational maternal weight and C19MC ICR mean methylation. (B) Scatter 4 
plot of maternal height and C19MC ICR mean methylation. (C) Scatter plot of pre-delivery 5 
maternal weight and C19MC ICR mean methylation. Pearson correlation statistics are shown 6 
within each box. 7 
 8 
Figure 2. Lower placental C19MC ICR methylation associated with greater offspring’s size 9 
and adiposity at 6 years of age. Scatter plots showing the correlation of placental C19MC ICR 10 
methylation levels with offspring’s weight z-score (A), height z-score (B), waist circumference 11 
(C), hip circumference (D), fat mass (E) and visceral fat volume (F) at 6 years of age. Pearson 12 
correlation statistics are shown in the boxes. 13 
 14 
Figure 3. Placental methylation levels at the C19MC ICR and gene expression. Scatter plot 15 
showing the correlation of placental C19MC ICR methylation levels with median C19MC gene 16 
expression (n=56). Pearson correlation statistics are shown in the box. 17 
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Table 1. Clinical assessments in the studied subjects. 
Mothers   N 72 
    Age at conception (yr) 30.7 ± 3.9 
    Primiparous (%) 58.6 
    Pre-gestational weight (Kg) 63.5 (55.0-78.0) 
  Height (cm) 162 (159-169) 
    Pre-gestational BMI (kg/m2) 23.6 (21.4-30.3) 
    Gestational weight gain (kg) 13.2 (10.8-17.2) 
    Pre-delivery weight (kg) 78.0 (69.1-93.4) 
Fathers   N 63 
  Weight (Kg) 80.0 (75.0-86.2) 
  Height (cm) 176 ± 6 
    BMI (kg/m2) 26.0 (24.2-27.2) 
Newborns N 72 
    Sex (% female) 51.4 
    Gestational age (wk) 40 ± 1 
    Weight (g) 3304 ± 367 
    Weight z-score 0.1 ± 0.9 
  Length (cm) 49.4 ± 1.8 
  Length z-score -0.3 ± 1.0 
Follow-up at age 6 years N 32 
    Age (yr) 5.8 ± 0.8 
    Sex (% female) 58 
  Weight (kg) 22.0 ± 3.8 
  Weight z-score 0.1 ± 0.9 
  Height (cm) 116 ± 6 
  Height z-score 0.2 ± 1.3 
    BMI (kg/m2) 16.2 (15.1-17.2) 
  BMI z-score 0.0 ± 0.8 
    Waist circumference (cm) 56.2 ± 6.6 
    Hip circumference (cm) 58.5 ± 7.1 
  
Fat mass (%) 22.1 ± 8.8 
    Visceral fat volume (mm3) 5.3 ± 1.2 
BMI: body-mass index. 
Data are expressed as mean ± SD or median (interquartile range) for Gaussian and non-
Gaussian variables, respectively. 
 2 
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Table 2. Six independent multivariate linear models of placental C19MC ICR methylation 
levels and children's characteristics at follow-up (age of 6, n=32). 
 β p Total R2 
Weight (kg)   0.44 
C19MC ICR mean methylation (%) -0.552 0.003  
Age(y) 0.325 0.039  
Non-explaining variables: sex, birth weight z-score, pre-gestational maternal weight. 
Height (cm)   0.39 
C19MC ICR mean methylation (%) -0.486 0.009  
Age (Y) 0.361 0.022  
Non-explaining variables: sex, birth length z-score, maternal height. 
Waist circumference (cm)   0.33 
C19MC ICR mean methylation (%) -0.497 0.003  
Non-explaining variables: sex, age. 
Hip circumference (cm)   0.41 
C19MC ICR mean methylation (%) -0.449 0.004  
Age (y) 0.412 0.007  
Non-explaining variables: sex. 
Fat mass (%)   0.56 
C19MC ICR mean methylation (%) -0.428 0.004  
Sex 0.502 <0.0001  
Non-explaining variables: age, BMI (Body-mass index). 
Visceral fat (mm3)   0.72 
Age (y) 0.523 <0.0001  
BMI (kg/m2) 0.456 <0.0001  
Non-explaining variables: sex, C19MC ICR mean methylation. 
 2 
In bold: dependent variable for each multivariate linear model. 3 
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SUPPLEMENTAL MATERIAL 1 
TABLES 2 
 3 
Table S1. Primer sequences for bisulfite PCR and pyrosequencing of C19MC ICR, 
corresponding to chr19:53648001-53648160 (hg38). 
  Sequence 
Product 
length (bp) 
Forward primer 5'-TGTTTGGAAAGGGGTTGTTTATGTA-3' 
160 
Reverse primer 5'-Biotin-CCCTCAAAAAAAAACCAAAATATTAATTC-3' 
Sequencing primer 5'-GTTTTGGATAGAGGTTTTTAGAG-3'   
 4 
5 
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Table S2. Pearson correlation coefficients between maternal and offspring’s 
anthropometry. 
  Offspring’s variables 
  
Birth Height 
SDS (n=72) 
Height SDS 
at 6 years 
(n=32) 
Birth Weight 
SDS (n=72) 
Weight SDS 
at 6 years 
(n=32) 
BMI SDS at 
6 years 
(n=32) 
 Maternal variables  
Height 0.257* 0.316* ns ns ns 
Pregestational weight ns ns 0.286* 0.329* ns 
Predelivery weight ns ns 0.350** 0.450** ns 
Pregestational BMI  ns ns ns ns 0.318* 
BMI: body-mass index; SDS: standard deviation score; ns: non-significant.  
*p≤0.05; **p≤0.01 
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Table S3. Pearson correlation coefficients between parental anthropometry, the 
percentage of methylation at placental C19MC ICR for each studied CpG and the mean 
overall methylation. 
    C19MC ICR methylation levels (%) 
    
CpG1 CpG2 CpG3 CpG4 CpG5 
Mean of 
all 5 CpGs 
Mothers' parameters (n=72) 
Pre-gestational weight  -0.280* -0.312** -0.286** -0.276* -0.336** -0.316** 
Height -0.286** -0.223 0.279* -0.237* -0.338** -0.291** 
Pre-gestational BMI  -0.197 -0.261* -0.207 -0.214 -0.239* -0.237* 
Gestational weight gain  0.014 0.027 -0.039 -0.011 -0.184 -0.052 
Pre-delivery weight  -0.324** -0.332** -0.338** -0.315** -0.441*** -0.376** 
Fathers' parameters (n=63) 
Weight  -0.059 -0.012 -0.038 -0.061 -0.015 -0.025 
Height -0.060 0.011 -0.109 -0.112 0.002 -0.054 
BMI  -0.040 -0.011 -0.010 -0.016 -0.018 -0.002 
BMI: body-mass index 
*p≤0.05; **p≤0.01; ***p≤0.001 
Correlations that remained significant after multiple testing correction (p≤0,01; see text) are highlighted in bold. 
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Table S4. Three independent multivariate linear models of placental C19MC ICR 
methylation levels (n=72) and maternal characteristics. 
    
β p R2 
C19MC ICR mean methylation (%)       
Pre-gestational weight (kg) -0.307 0.011 0.05 
Non-explaining variables: maternal age, gestational age and child’s sex. 
    β P R
2 
C19MC ICR mean methylation (%)    
Height (cm) -0.294 0.019 0.04 
Non-explaining variables: maternal age, gestational age and child’s sex. 
 
 
    
β P R2 
C19MC ICR mean methylation (%)       
 Pre-delivery weight (Kg)  -0.371 0.003 0.10 
Non-explaining variables: maternal age, gestational age and child’s sex. 
2 
In bold: dependent variables in each multivariate linear model. 
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Table S5. Percentage of C19MC ICR methylation levels and the corresponding 
parentally transmitted alleles (n=53). 
  C19MC ICR methylation levels (%) 
  
n CpG1 CpG2 CpG3 CpG4 CpG5 
Mean of 
all 5 CpGs 
Maternally transmitted allele 
T 44 41.8 ± 1.1 42.1 ± 1.2 44.2 ± 1.2 42.2 ± 1.2 42.5 ± 1.8 42.6 ± 1.2 
G 9 44.7 ± 3.2 45.7 ± 2.6 46.9 ± 2.7 46.4 ± 2.7 46.4 ± 3.0 46.0 ± 2.8 
Paternally transmitted allele 
T 32 40.6 ± 1.3 40.5 ± 1.4 43.1 ± 1.5 41.1 ± 1.4 39.8 ± 2.0* 41.0 ± 1.4 
G 21 43.9 ± 1.6 44.6 ± 1.7 46.1 ± 1.6 44.7 ± 1.7 47.2 ± 2.0 45.3 ± 1.6 
Results are mean ± SEM.*p≤0.05 for an unpaired Student’s T-test.  
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Table S6. Pearson correlation coefficients between children’s variables and the 
percentage of methylation at placental C19MC ICR for each studied CpG and the overall 
methylation. 
    C19MC ICR methylation levels (%) 
    
CpG1 CpG2 CpG3 CpG4 CpG5 
Mean of 
all 5 CpGs 
Children's parameters at birth (n=72) 
Placental weight (g) -0.035 0.009 -0.041 -0.032 -0.086 -0.042 
Weight (g) -0.103 -0.085 -0.140 -0.147 -0.179 -0.141 
Weight z-score -0.005 -0.022 -0.101 -0.082 -0.144 -0.081 
Length (cm) -0.127 -0.095 -0.122 -0.186 -0.177 -0.152 
Length z-score -0.046 -0.034 -0.084 -0.130 -0.150 -0.098 
Children's parameters at age 6 years (n=32) 
Weight (kg) -0.546*** -0.636*** -0.547*** -0.575*** -0.629*** -0.607*** 
Weight z-score -0.543*** -0.567*** -0.548*** -0.588*** -0.591*** -0.588** 
Height (cm) -0.569*** -0.578*** -0.518** -0.592*** -0.522** -0.573*** 
Height z-score -0.531** -0.444** -0.483** -0.581*** -0.412* -0.504** 
BMI (kg/m2) -0.325 -0.451** -0.379* -0.352* -0.508** -0.420* 
BMI z-score -0.282 -0.402* -0.338 -0.312 -0.412* -0.377* 
Waist circumference 
(cm) 
-0.438** -0.568*** -0.466** -0.448** -0.568*** -0.516*** 
Hip circumference 
(cm) 
-0.427** -0.559*** -0.456** -0.445** -0.532** -0.501** 
Fat mass (%) -0.458** -0.505** -0.505** -0.386* -0.459** -0.482** 
Visceral fat volume 
(mm3) 
-0.396* -0.524** -0.431** -0.377* -0.472** -0.455** 
BMI: body-mass index 
*p≤0.05; **p≤0.01; ***p≤0.001. Highlighted in bold are those correlations that remained significant after multiple 
testing correction (p<0,0125; see text). 
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FIGURES 2 
Figure S1. C19MC locus and methylation levels. (A) Localization of the C19MC ICR (Imprinting 3 
Control Region). The region analyzed for methylation studies was chr19:53648001-53648160, 4 
and the SNP (rs55765443) localization was chr19:53665044 according to the GRCh38/hg38 5 
assembly. (B) C19MC ICR methylation levels in placenta. Boxplots show the percentage of 6 
DNA methylation in C19MC ICR (boxes represent median ± interquartile range) for each CpG 7 
and average of percent methylation for all studied CpGs within the C19MC ICR.  8 
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Figure 21 
S2. 22 
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Parentally transmitted alleles for the rs55765443 SNP and placental C19MC ICR methylation. 1 
(A) Mean methylation levels at C19MC ICR according to the maternally transmitted allele 2 
(p=0.271). (B) Mean methylation levels at C19MC ICR according to the paternally transmitted 3 
allele (p=0.059).    4 
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